Page 34 - 78 glossary of hivaids-related terms_opt

Comprehensive International Program of Research on AIDS (CIPRA)
A program administered by the National Institute of Allergy and
Infectious Diseases (NIAID) to support research and development of
C practical, affordable, and acceptable methods to prevent and treat
HIV/AIDS in resource-poor countries.

Concentration
The relative amount of a substance, such as an administered drug
or a circulating enzyme, found in a particular location, such as the
blood or a specific organ. For example, drug concentrations are often
reported as the amount of drug in a measured sample of blood.
See Also: CMIN
CMAX

Condyloma Acuminatum
See: Genital Warts

Contagious
Easily passable between people through normal day-to-day
contact. For example, chicken pox is both an infectious (causing
infection) and a contagious disease. In contrast, HIV is an example
of an infectious disease that is not a contagious disease (i.e., it
cannot be passed from person to person through casual contact).

Contraindication
A specific situation in which a particular treatment should NOT be
used, because it may be harmful to the patient. For example, some
anti-HIV drugs are primarily broken down by the liver and should not
be given to people who have liver damage.

Controlled Trial
A control is a standard against which experimental treatments may
be compared and evaluated for safety and effectiveness. In clinical
trials, one group of patients may be given an experimental drug,
while another group (the control group) is given either a standard
treatment for the disease or a placebo.
See Also: Placebo

32 HIV/AIDS Glossary